// App-Quantinova.ai

: Ibrutinib for Steroid Refractory Chronic Graft Vs Host Disease - Real World Experience

Researchers

Presenter

  • Gaurav Sutrave

Principal Investigators

  • Tishya Indran

  • Yatika Jivan

  • Andrew Hutchison

  • Nada Hamad

  • Sui Tan

  • Duncan Purtill

  • Andrew Grigg

  • Siok-keen Tey

  • David J. Curtis

  • David J Gottlieb

  • Abir Bhattacharyya

Medical Centers

  • Department of Bone Marrow Transplantation, Royal Brisbane and Womens Hospital, Herston, Australia

  • St. Vincent's Hospital, Sydney, Australia

  • Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, St Kilda East, Melbourne, Australia

  • QIMR Berghofer Medical Research Institute, Brisbane, Australia

  • Royal Perth Hospital, Shenton Park, Australia

  • Faculty of Medicine and Health, University of Sydney, Sydney, Australia

  • Department of Haematology, Westmead Hospital, Westmead, Australia

  • Blood Clinic, St John of God Healthcare, Murdoch, Australia

  • Department of Haematology and BMT, Royal Brisbane and Women's Hospital, Brisbane, Australia

  • Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, Australia

  • Department of Haematology, St Vincent's Hospital Sydney, Australia and St Vincent's Clinical School, Sydney, University of New South Wales, Sydney, Australia

  • Department of Clinical Haematology, Austin Health, Heidelberg, Australia

  • Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Ibrutinib

Outcome

  • N/A


Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A